If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,400.00    0.00 (0.00%)
Bid:
5,350.00
Ask:
5,500.00
Spread: 150.00 (2.804%)
Market Cap: £136.50m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

BF&M Strategic Review

30 Jun 2022 07:00

RNS Number : 7264Q
Camellia PLC
30 June 2022
 

30 June 2022

Camellia Plc

 

(the "Company" or the "Group")

 

Associate company update

 

Camellia Plc (CAM.L) announces that its 37.4% owned associate company, BF&M Limited ("BF&M"), a listed Bermudian insurance business, yesterday issued a statement that in order to maximise shareholder value, it has initiated a review of strategic alternatives for the business. This may include a range of outcomes for BF&M, including, inter alia, the sale of BF&M. The full text of BF&M's announcement can be found in Appendix 1 to this announcement.

 

There can be no guarantee as to the outcome of the BF&M strategic review. A further announcement will be made in due course as and when appropriate.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

 

Appendix 1 BF&M announces Strategic Review

Hamilton, Bermuda. 29 June 2022- BF&M Limited (BF&M or the 'Company') (BSX:BFM) announced today that, following discussions with its principal 37.4% shareholder, the Board of Directors ( the 'Board') has initiated a review of strategic alternatives (the Strategic Review) to maximise shareholder value and which may include the sale of the Company.

 

The Board has established a special committee (Special Committee), chaired by Group Chairman and Chief Executive Officer John Wight and including Jennifer Reynolds and Anthony Joaquin, both independent directors, to oversee the Strategic Review. The Special Committee has retained Desjardins Capital Markets to assist it in this process.

 

John Wight stated: 'Throughout and beyond the Strategic Review process, BF&M will remain focused on enhancing corporate value by steadily carrying out business activities, delivering excellent customer service and executing on our long-term strategy.'

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSESESUEESEDM
Date   Source Headline
2nd Jun 201010:22 amRNSAnnual Information Update
6th May 20104:06 pmRNSAnnual Financial Report
29th Apr 20103:04 pmRNSAnnual Financial Report
15th Apr 20102:08 pmRNSDisposal
1st Apr 201011:10 amRNSAppointment of Joint Managing Directors
26th Mar 201010:30 amRNSDirectorate Change
25th Mar 201011:59 amRNSInterim Management Statement
8th Mar 20107:00 amRNSDisposal
5th Mar 20107:00 amRNSStatement Re Siegfried Holding AG
28th Oct 20093:20 pmRNSInterim Management Statement
13th Oct 200910:06 amRNSCircular regarding change of auditor
14th Sep 20094:00 pmRNSDisposal
8th Sep 200910:44 amRNSHalf Yearly Report
27th Aug 200911:00 amRNSHalf Yearly Report
29th Jun 20094:40 pmRNSSecond Price Monitoring Extn
29th Jun 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20094:40 pmRNSSecond Price Monitoring Extn
10th Jun 20094:35 pmRNSPrice Monitoring Extension
4th Jun 20091:40 pmRNSResult of AGM
3rd Jun 20094:40 pmRNSSecond Price Monitoring Extn
3rd Jun 20094:35 pmRNSPrice Monitoring Extension
3rd Jun 200912:12 pmRNSAGM Statement
29th May 20092:55 pmRNSAnnual Information Update
6th May 20092:00 pmRNSAnnual Report and Accounts
28th Apr 20096:26 pmRNSAnnual Financial Report
26th Mar 20092:20 pmRNSInterim Management Statement
2nd Feb 20094:35 pmRNSPrice Monitoring Extension
3rd Dec 20082:23 pmRNSDirector/PDMR Shareholding
24th Nov 20083:37 pmRNSHolding(s) in Company
21st Oct 20084:44 pmRNSSecond Price Monitoring Extn
21st Oct 20084:37 pmRNSPrice Monitoring Extension
2nd Oct 20082:30 pmRNSInterim Management Statement
29th Sep 20082:02 pmRNSDirectorate Change
17th Sep 20083:08 pmRNSInterim Report
28th Aug 20083:29 pmRNSInterim Results
6th Jun 200812:52 pmRNSResult of AGM
5th Jun 200812:13 pmRNSAGM Statement
30th May 20082:41 pmRNSAnnual Information Update
21st May 200811:49 amRNSDirector/PDMR Shareholding
13th May 20083:41 pmRNSDirector/PDMR Shareholding
8th May 20084:04 pmRNSDirector/PDMR Shareholding
2nd May 200812:19 pmRNSAnnual Report and Accounts
29th Apr 20084:12 pmRNSDirector/PDMR Shareholding
24th Apr 200812:35 pmRNSPreliminary announcement
27th Mar 20083:09 pmRNSInterim Management Statement
4th Oct 20073:16 pmRNSInterim Report
27th Sep 200712:30 pmRNSInterim Results
9th Aug 20074:24 pmRNSHolding(s) in Company
8th Jun 20074:06 pmRNSResult of AGM
7th Jun 200712:15 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.